Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T‐cell lymphomas
- 11 July 2021
- journal article
- research article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 20 (1) , 118-126
Abstract
Canine cutaneous lymphoma is an uncommon lymphoma in dogs. Most canine cutaneous lymphoma cases have a T‐cell origin. Canine cutaneous T‐cell lymphoma (CTCL) is classified into epitheliotropic and nonepitheliotropic cutaneous lymphomas, and each type of lymphoma is subclassified into several histological subtypes. Limited information is available regarding the prognostic significance of clinical variables and histopathological subtypes in dogs with CTCL. This retrospective study aimed to investigate the influence of clinical variables and histopathological subtypes on the prognosis of dogs with CTCL. Forty‐six dogs diagnosed with CTCL by histopathological examination were included. Histopathological specimens were reexamined and classified into CTCL subtypes. The influence of the type of skin lesion, histopathological subtype, haematological examination results and treatment response on the overall survival time (OS) was examined. Thirty‐one dogs were diagnosed with epitheliotropic CTCL (mycosis fungoides in 28 dogs; pagetoid reticulosis in 3 dogs) and 15 dogs were diagnosed with nonepitheliotropic CTCL (anaplastic large T‐cell lymphoma in 6 dogs; peripheral T‐cell lymphoma, not otherwise specified, in 9 dogs). The OS of dogs diagnosed with epitheliotropic CTCL (141 days) was significantly shorter than that of dogs diagnosed with nonepitheliotropic CTCL (374 days). As clinical variables, the presence of neoplastic lymphocytes in peripheral blood, thrombocytopenia and initial chemotherapeutic response was related to prognosis. Our results demonstrated that histopathological subtype and several clinical variables were found to influence the prognosis of dogs with CTCL.Keywords
This publication has 27 references indexed in Scilit:
- Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus documentVeterinary and Comparative Oncology, 2013
- Gene transcription analysis in lesional skin of canine epitheliotropic cutaneous lymphoma using quantitative real-time RT-PCRVeterinary Immunology and Immunopathology, 2011
- Primary cutaneous CD20-positive T-cell lymphomaJournal of Cutaneous Pathology, 2011
- Canine epitheliotropic cutaneous T‐cell lymphoma: an investigation of T‐cell receptor immunophenotype, lesion topography and molecular clonalityVeterinary Dermatology, 2009
- Combination Chemotherapy with Continuous l -Asparaginase, Lomustine, and Prednisone for Relapsed Canine LymphomaJournal of Veterinary Internal Medicine, 2009
- Canine cutaneous epitheliotropic T‐cell lymphoma: a reviewVeterinary and Comparative Oncology, 2009
- Response of Canine Cutaneous Epitheliotropic Lymphoma to Lomustine (CCNU): A Retrospective Study of 46 Cases (1999–2004)Journal of Veterinary Internal Medicine, 2006
- CCNU in the Treatment of Canine Epitheliotropic LymphomaJournal of Veterinary Internal Medicine, 2006
- Evaluation of a 6-Month Chemotherapy Protocol with No Maintenance Therapy for Dogs with LymphomaJournal of Veterinary Internal Medicine, 2002
- Cutaneous lymphomas in companion animalsClinics in Dermatology, 1994